Literature DB >> 22865354

Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.

Vasundhara S Chennuri1, Shilpa M Mithbawkar, Rajashree A Mokal, Meena P Desai.   

Abstract

OBJECTIVES: To determine the variables affecting serum 17 hydroxyprogesterone (17OHP) in neonates born at a tertiary hospital in Mumbai, India.
METHODS: Serum 17OHP was measured in peripheral venous blood between 3rd to 5th day of life by competitive radioimmunoassay and on follow up at 3 mo of age. Serum 17OHP was compared among four groups [full term healthy(FT), full term stressed(FS), preterm healthy(PT), preterm stressed(PS)] by non-parametric tests (Kruskal Wallis (KW) test and Mann- Whitney (MW) test). Pearson's test was used to correlate natural log of serum 17OHP (ln17OHP) with variables like gestational age, birth weight, stress factor, sex, antenatal administration of glucocorticoids to mothers, Apgar score at 5 min and mode of delivery. Linear regression analysis was done using significant variables in Pearson's test to determine best predictors of ln17OHP.
RESULTS: The initial median (number of cases, inter-quartile range) serum 17OHP (ng/ml) for the four groups was as follows; FT 8.4 (33, 6-13); PT 20 (36, 11-29.5); FS 34 (29, 26-45) and PS 58 (24, 40.75-76.5) [total N = 122 newborns, p = 0.001]. Pearson's test showed that gestational age, birth weight, stress factor, Apgar score were negatively correlated with 17OHP whereas stress factor, mode of delivery, use of antenatal steroids in mothers were significantly positively correlated. However, stress factor emerged as the most important significant positive predictor (multiple R = 0.643, P = <0.0001). On follow up at 3 mo age, the median 17OHP (N = 73 newborns) had significantly decreased to normal level.
CONCLUSION: Stress due to neonatal illnesses like meconium aspiration, sepsis, birth asphyxia, etc. significantly elevate serum 17OHP and may lead to false positives in newborn screening for congenital adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865354     DOI: 10.1007/s12098-012-0856-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

Review 1.  Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.

Authors: 
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.

Authors:  Bernhard Olgemöller; Adelbert A Roscher; Bernhard Liebl; Ralph Fingerhut
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 3.  Developmental and functional biology of the primate fetal adrenal cortex.

Authors:  S Mesiano; R B Jaffe
Journal:  Endocr Rev       Date:  1997-06       Impact factor: 19.871

4.  Placental estrogen biosynthesis during human pregnancy.

Authors:  P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

5.  Immature adrenal steroidogenesis in preterm infants.

Authors:  S Nomura
Journal:  Early Hum Dev       Date:  1997-10-10       Impact factor: 2.079

6.  Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.

Authors:  J F Murphy; B G Joyce; J Dyas; I A Hughes
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

Review 7.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P C White; P W Speiser
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

Review 8.  Congenital adrenal hyperplasia.

Authors:  S Pang
Journal:  Endocrinol Metab Clin North Am       Date:  1997-12       Impact factor: 4.741

9.  Newborn screening in India.

Authors:  A Radha Rama Devi; S M Naushad
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

10.  Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.

Authors:  Frédérique Gatelais; Jacques Berthelot; Frédérique Beringue; Philippe Descamps; Dominique Bonneau; Jean-Marie Limal; Régis Coutant
Journal:  Pediatr Res       Date:  2004-09-15       Impact factor: 3.756

View more
  3 in total

Review 1.  Congenital adrenal hyperplasia: issues in diagnosis and treatment in children.

Authors:  Rajni Sharma; Anju Seth
Journal:  Indian J Pediatr       Date:  2013-11-20       Impact factor: 1.967

2.  Newborn Screening for Congenital Hypothyroidism and Congenital Adrenal Hyperplasia.

Authors: 
Journal:  Indian J Pediatr       Date:  2018-03-17       Impact factor: 1.967

3.  17-hydroxiprogesterone values in healthy preterm infants.

Authors:  Víctor Clemente Mendoza-Rojas; Luis Alfonso Díaz-Martínez; Gerardo Mantilla-Mora; Gustavo Adolfo Contreras-García; Víctor Manuel Mora-Bautista; Jhon Freddy Martínez-Paredes; Alba Luz Calderón-Rojas; Carlos Augusto Gómez-Tarazona; Katherine Pinzón-Mantilla
Journal:  Colomb Med (Cali)       Date:  2017-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.